Clinical Trials Browser

Bupropion × 1 year × Clear all

NCT03180294 2026-05-19

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Phase 2 Completed

230 enrolled 24 charts

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT07596212 2026-05-19

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

Phase 1/2 Not yet recruiting

Breast Neoplasms, Sexual Dysfunctions, Psychological

NCT05646862 2026-05-06

INAVO121

Phase 3 Active not recruiting

Breast Neoplasms

NCT07235748 2026-02-17

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Phase 1 Completed

Healthy Adult Participants

NCT04634071 2026-02-02

TTOP

Phase 2 Completed

Smoking Cessation, Neoplasms, Second Primary, Behavior, Addictive

NCT03996265 2026-01-15

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Phase 3 Active not recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT04694846 2025-09-09

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

Phase NA Completed

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung

NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Active not recruiting

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias